Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia

Haematologica

Volumn 95, Issue 8, 2010, Pages 1420-1424

  Hou, Hsin An ^a   Shih, Tiffany Ting Fang ^a   Liu, Chieh Yu ^b   Chen, Bang Bin ^a   Tang, Jih Luh ^a   Yao, Ming ^a   Huang, Shang Yi ^a   Chou, Wen Chien ^a   Hsu, Chao Yu ^a   Tien, Hwei Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Acute myeloid leukemia; Bm angiogenesis; DCE MRI; Outcome

Indexed keywords

ANTHRACYCLINE; CYTARABINE; GADOLINIUM PENTETATE MEGLUMINE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW DISEASE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; TREATMENT RESPONSE; TUMOR VASCULARIZATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954591162     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.019364     Document Type: Article

References (22)

1. Moehler TM, Ho AD, Goldschmidt H, Barlogie B. Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol. 2003;45(3):227-244.
2. Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000;95(8):2637-2644.
3. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood. 2000;95(1):309-313.
4. Hou HA, Chou WC, Lin LI, Tang JL, Tseng MH, Huang CF, et al. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia. Leuk Res. 2008;32(6):904-912.
5. Shih TT, Tien HF, Liu CY, Su WP, Chan WK, Yang PC. Functional MR imaging of tumor angiogenesis predicts outcome of patients with acute myeloid leukemia. Leukemia. 2006;20(2):357-362.
6. Matuszewski L, Persigehl T, Wall A, Meier N, Bieker R, Kooijman H, et al. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience. Radiology. 2007;242(1):217-224.
7. Wilson CS, Davidson GS, Martin SB, Andries E, Potter J, Harvey R, et al. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood. 2006;108(2):685-696.
8. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92(7):2322-2333.
9. Ventura GJ, Hester JP, Smith TL, Keating MJ. Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction. Am J Hematol. 1988;27(1):34-37.
10. Hiddemann W, Clarkson BD, Buchner T, Melamed MR, Andreeff M. Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia. Blood. 1982;59(2):216-225.
11. Preisler H, Barcos M, Reese P, Priore RL, Pothier L. Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy. Leuk Res.1983;7(1):67-75.
12. Roberts MM, Juttner CA, To LB, Kimber RJ. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease. Leuk Res. 1988;12(10):817-821.
13. Kuzu I, Beksac M, Arat M, Celebi H, Elhan AH, Erekul S. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival. Leuk Lymphoma.2004;45(6):1185-1190.
14. Rabitsch W, Sperr WR, Lechner K, Chott A, Prinz E, Valent P, et al. Bone marrow microvessel density and its prognostic significance in AML. Leuk Lymphoma. 2004;45(7):1369-1373.
15. Shih TT, Hou HA, Liu CY, Chen BB, Tang JL, Chen HY, et al. Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival. Blood. 2009;113(14):3161-3167.
16. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15(4):621-628.
17. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrastenhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223-232.
18. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991;17(2):357-367.
19. Chen WT, Shih TT, Chen RC, Lo SY, Chou CT, Lee JM, et al. Vertebral bone marrow perfusion evaluated with dynamic contrastenhanced MR imaging: significance of aging and sex. Radiology. 2001;220(1):213-218.
20. Archimbaud E, Treille-Ritouet D, Guyotat D, Viala JJ, Fiere D. Day 4 bone marrow aspirate for prediction of resistance to induction chemotherapy in acute myeloid leukemia. Leuk Res.1987;11(3):281-283.
21. Preisler HD, Priore R, Azarnia N, Barcos M, Raza A, Rakowski I, et al. Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements. Br J Haematol. 1986;63(4):625-636.
22. Cassileth PA, Gerson SL, Bonner H, Neiman RS, Lusk EJ, Hurwitz S. Identification of early relapsing patients with adult acute nonlymphocytic leukemia by bone marrow biopsy after initial induction chemotherapy. J Clin Oncol. 1984; 2(2):107-111.